Transcreener® High Throughput Screening Assays for Glycosyltransferases
7 Jan 2015Identifying glycosyltransferase inhibitors remains a challenging task in drug discovery, because for many enzymes in this diverse class, screening methods have been limited to expensive and cumbersome radiolabeled assays or HPLC/MS analyses. As shown here, over the last few years Transcreener® glyscosyltransferase assays have been developed based on the simple and direct immunodetection of nucleotides, which are easily adaptable to automation and systemized high throughput screening protocols.
Related Products
Request Quote for All Products
Transcreener® GDP GTPase Assays
BellBrook LabsThe Transcreener® GDP GTPase Assay Kit directly measures GDP produced during GTP hydrolysis in a homogeneous mix‑and‑read format—no coupling enzymes needed. Compatible with GTPases, GAPs, and GEFs, it supports FP, FI, and TR‑FRET readouts using far‑red tracers to reduce interference. HTS‑ready with excellent sensitivity (Z′ ≥ 0.7), it streamlines screening and profiling workflows.
Transcreener® AMP²/GMP² Phosphodiesterase Assays
BellBrook LabsThe Transcreener® AMP²/GMP² Phosphodiesterase Assay Kit directly detects AMP or GMP produced by PDEs, ligases, synthetases, ENPP1, and related enzymes using a mix‑and‑read FP or TR‑FRET format—no coupling steps needed. Compatible with 1–1000 µM native substrates, it delivers excellent HTS performance (Z’ ≥ 0.7, ≥100 mP shift) in a one-step, far‑red fluorescence assay.
Transcreener® UDP² Glycosyltransferase Assays
BellBrook LabsThe Transcreener® UDP² Glycosyltransferase Assay Kit directly detects UDP—the conserved product of glycosyltransferase reactions—in a homogeneous mix-and-read format. Compatible with FP, FI, and TR‑FRET readouts, it supports UDP concentrations from 1–250 µM and delivers exceptional HTS performance (Z’ ≥ 0.7) across 96-, 384-, and 1536‑well formats.